Nuveen Asset Management, LLC Intercept Pharmaceuticals, Inc. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$9.99 - $18.71 $1.07 Million - $2.01 Million	-107,194 Reduced 24.77%	325,552 $6.04 Million
Q2 2023 Aug 14, 2023	SELL	$9.17 - $19.29 $3.51 Million - $7.38 Million	-382,702 Reduced 46.93%	432,746 $4.79 Million
Q1 2023 May 15, 2023	BUY	$12.53 - $21.71 $219,751 - $380,749	17,538 Added 2.2%	815,448 $11 Million
Q4 2022 Feb 14, 2023	BUY	$11.61 - $16.11 $4.48 Million - $6.22 Million	385,884 Added 93.66%	797,910 $9.87 Million
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $1.15 Million - $1.86 Million	94,515 Added 29.77%	412,026 $5.75 Million
Q2 2022 Aug 15, 2022	BUY	$11.23 - $19.59 $2.19 Million - $3.81 Million	194,584 Added 158.29%	317,511 $4.39 Million
Q1 2022 May 16, 2022	BUY	$13.37 - $17.79 $572,917 - $762,319	42,851 Added 53.51%	122,927 $2.02 Million
Q4 2021 Feb 14, 2022	SELL	$14.28 - $19.53 $113,040 - $154,599	-7,916 Reduced 9.0%	80,076 $1.1 Million
Q3 2021 Nov 12, 2021	SELL	$12.99 - $20.47 $77,069 - $121,448	-5,933 Reduced 6.32%	87,992 $1.4 Million
Q2 2021 Aug 16, 2021	SELL	$15.46 - $24.5 $44,586 - $70,658	-2,884 Reduced 2.98%	93,925 $1.88 Million
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $11,269 - $22,008	-583 Reduced 0.6%	96,809 $2.23 Million
Q4 2020 Feb 16, 2021	SELL	$24.48 - $42.47 $3.05 Million - $5.28 Million	-124,393 Reduced 56.09%	97,392 $2.41 Million
Q3 2020 Nov 16, 2020	BUY	$39.09 - $53.44 $4.6 Million - $6.29 Million	117,740 Added 113.16%	221,785 $9.2 Million
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $43,804 - $86,333	-938 Reduced 0.89%	104,045 $4.99 Million
Q1 2020 May 14, 2020	SELL	$48.35 - $118.68 $362,721 - $890,337	-7,502 Reduced 6.67%	104,983 $6.61 Million
Q4 2019 Feb 14, 2020	SELL	$57.36 - $124.1 $88,449 - $191,362	-1,542 Reduced 1.35%	112,485 $13.9 Million
Q3 2019 Nov 14, 2019	SELL	$58.69 - $80.46 $402,848 - $552,277	-6,864 Reduced 5.68%	114,027 $7.57 Million
Q2 2019 Aug 15, 2019	BUY	$77.77 - $120.68 $8.83 Million - $13.7 Million	113,549 Added 1546.57%	120,891 $9.62 Million
Q1 2019 May 14, 2019	BUY	$91.83 - $120.68 $674,215 - $886,032	7,342 New	7,342 $821,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account